Lion Partners with SAP Founder to Acquire Axaron Bioscience and Build New Drug-Development Firm | GenomeWeb
NEW YORK (GenomeWeb News) - Lion Bioscience said yesterday that it has acquired the operational business of Axaron Bioscience to create a drug-development firm with a focus on central nervous system disorders.    
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.